Age-dependent vulnerability of the striatum to the mitochondrial toxin 3-nitropropionic acid

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

Beal, M. F. (1992) · Annals of Neurology · doi:10.1002/ana.410310202 · Cited by 962

Glutamate becomes neurotoxic via the N-methyl-d-aspartate receptor when intracellular energy levels are reduced

Novelli, A., Reilly, J. A., Lysko, P. G., & Henneberry, R. C. (1988) · Brain Research · doi:10.1016/0006-8993(88)90765-2 · Cited by 961

Decline in skeletal muscle mitochondrial respiratory chain function: possible factor in ageing

Trounce, I., Byrne, E., & Marzuki, S. (1989) · The Lancet · doi:10.1016/s0140-6736(89)92143-0 · Cited by 730

Evidence for Degenerative and Regenerative Changes in Neostriatal Spiny Neurons in Huntington's Disease

Graveland, G. A., Williams, R. S., & DiFiglia, M. (1985) · Science · doi:10.1126/science.3155875 · Cited by 612

3-Nitropropionic Acid - Exogenous Animal Neurotoxin and Possible Human Striatal Toxin

Ludolph, A. C., He, F., Spencer, P. S., Hammerstad, J. P., & Sabri, M. I. (1991) · Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques · doi:10.1017/s0317167100032212 · Cited by 484

3-Nitropropionate, the toxic substance of Indigofera , is a suicide inactivator of succinate dehydrogenase

Alston, T. A., Mela, L., & Bright, H. J. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.9.3767 · Cited by 382

Proliferative and degenerative changes in striatal spiny neurons in Huntington's disease: a combined study using the section-Golgi method and calbindin D28k immunocytochemistry

Ferrante, R., Kowall, N., & Richardson, E. (1991) · The Journal of Neuroscience · doi:10.1523/jneurosci.11-12-03877.1991 · Cited by 306

Nature and distribution of brain lesions in rats intoxicated with 3-nitropropionic acid: A type of hypoxic (energy deficient) brain damage

Hamilton, B. F., & Gould, D. H. (1987) · Acta Neuropathologica · doi:10.1007/bf00691103 · Cited by 230

1‐Methyl‐4‐Phenylpyridinium Produces Excitotoxic Lesions in Rat Striatum as a Result of Impairment of Oxidative Metabolism

Storey, E., Hyman, B. T., Jenkins, B. G., Brouillet, E., Miller, J. M., Rosen, B. R., & Beal, M. F. (1992) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1992.tb10080.x · Cited by 164

Chemically induced hypoglycemia and anoxia: relationship to glutamate receptor-mediated toxicity in retina.

Zeevalk, G. D., & Nicklas, W. J. (1990) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)13234-5 · Cited by 164

Inhibition of striatal energy metabolism produces cell loss in the ipsilateral substantia nigra

Sonsalla, P. K., Manzino, L., Sinton, C. M., Liang, C., German, D. C., & Zeevalk, G. D. (1997) · Brain Research · doi:10.1016/s0006-8993(97)00941-4 · Cited by 24

Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10

Brouillet, E., Henshaw, D. R., Schulz, J. B., & Beal, M. F. (1994) · Neuroscience Letters · doi:10.1016/0304-3940(94)90044-2 · Cited by 23

Trolox ameliorates 3-nitropropionic acid-induced neurotoxicity in rats

Mutairy, A. A., Kadasah, S., Elfaki, I., Arshaduddin, M., Malik, D., Moutaery, K. A., & Tariq, M. (2009) · Neurotoxicology and Teratology · doi:10.1016/j.ntt.2009.09.003 · Cited by 23

Selective striatal mtDNA depletion in end-stage Huntington's disease R6/2 mice

Hering, T., Birth, N., Taanman, J., & Orth, M. (2015) · Experimental Neurology · doi:10.1016/j.expneurol.2015.02.004 · Cited by 23

The Differential Vulnerability of Striatal Projection Neurons in 3-Nitropropionic Acid-Treated Rats Does Not Match That Typical of Adult-Onset Huntington's Disease

Sun, Z., Xie, J., & Reiner, A. J. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7947 · Cited by 22

Chapter 16 Neurodegeneration and glutamate induced oxidative stress

Nakao, N., & Brundin, P. (1998) · Progress in brain research · doi:10.1016/s0079-6123(08)60441-0 · Cited by 22

Functional interactions within striatal microcircuit in animal models of Huntington's disease

Ghiglieri, V., Bagetta, V., Calabresi, P., & Picconi, B. (2011) · Neuroscience · doi:10.1016/j.neuroscience.2011.06.075 · Cited by 19

Bioenergetics in fibroblasts of patients with Huntington disease are associated with age at onset

Gardiner, S. L., Milanese, C., Boogaard, M. W., Buijsen, R. A. M., Hogenboom, M., Roos, R. A. C., Mastroberardino, P. G., van Roon‐Mom, W., & Aziz, N. A. (2018) · Neurology Genetics · doi:10.1212/nxg.0000000000000275 · Cited by 20

Molecular biology of Huntington's disease

McFarland, K. N., & Cha, J.-H. J. (2011) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52014-2.00003-3 · Cited by 21

Animal models of cognitive dysfunction

Tayebati, S. K. (2005) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2005.09.026 · Cited by 22

Early nerve ending rescue from oxidative damage and energy failure by l-carnitine as post-treatment in two neurotoxic models in rat: recovery of antioxidant and reductive capacities

Elinos, D., Robledo-Arratia, Y., de la Cruz, V. P., Pedraza‐Chaverrí, J., Ali, S. F., & Santamarı́a, A. (2009) · Experimental Brain Research · doi:10.1007/s00221-009-1913-3 · Cited by 21

Ethics and Refinement in Animal Research

Olsson, I. A. S., Hansen, A. K., & Sandøe, P. (2007) · Science · doi:10.1126/science.317.5845.1680 · Cited by 21

Chemical Preconditioning with 3-Nitropropionic Acid in Gerbil Hippocampal Slices: Therapeutic Window and the Participation of Adenosine Receptor

Aketa, S., Nakase, H., Kamada, Y., Hiramatsu, K.-I., & Sakaki, T. (2000) · Experimental Neurology · doi:10.1006/exnr.2000.7507 · Cited by 21

A mitochondrial basis for Huntington’s disease: therapeutic prospects

Chakraborty, J., Rajamma, U., & Mohanakumar, K. P. (2013) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-013-1951-9 · Cited by 21

An Update of Kaempferol Protection against Brain Damage Induced by Ischemia-Reperfusion and by 3-Nitropropionic Acid

López‐Sánchez, C., Lagoa, R., Poejo, J., García‐López, V., García‐Martínez, V., & Gutiérrez‐Merino, C. (2024) · Molecules · doi:10.3390/molecules29040776 · Cited by 21

Psychotropic and Neurotropic Activity

Vogel, H. G. (2007) · Springer eBooks · doi:10.1007/978-3-540-70995-4_6 · Cited by 22

Reduced Mitochondrial Function in Human Huntington Disease Lymphoblasts is Not Due to Alterations in Cardiolipin Metabolism or Mitochondrial Supercomplex Assembly

Mejia, E. M., Chau, S., Sparagna, G. C., Sipione, S., & Hatch, G. M. (2016) · Lipids · doi:10.1007/s11745-015-4110-0 · Cited by 20

Clorgyline and deprenyl attenuate striatal malonate and 3-nitropropionic acid lesions

Maragos, W. F., Tillman, P. A., Chesnut, M. D., & Jakel, R. J. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01487-0 · Cited by 20

Differential responses of extracellular GABA to intrastriatal perfusions of 3-nitropropionic acid and quinolinic acid in the rat

Reynolds, N. C., Lin, W., Cameron, C. M., & Roerig, D. L. (1997) · Brain Research · doi:10.1016/s0006-8993(97)01048-2 · Cited by 20

Experimental Models of HD and Reflection on Therapeutic Strategies

Kim, J., Bordiuk, O. L., & Ferrante, R. J. (2011) · International review of neurobiology · doi:10.1016/b978-0-12-381328-2.00016-x · Cited by 20

AN EXPEDITIOUS SYNTHESIS OF 3-NITROPROPIONIC ACID AND ITS ETHYL AND METHYL ESTERS

Silva, P. C., Costa, J. S., & Pereira, V. L. P. (2001) · Synthetic Communications · doi:10.1081/scc-100000587 · Cited by 19

Glabridin protects osteoblastic MC3T3-E1 cells against antimycin A induced cytotoxicity

Choi, E. M. (2011) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2011.05.007 · Cited by 18

Exaggerated mitophagy: a weapon of striatal destruction in the brain?

Subramaniam, S. (2020) · Biochemical Society Transactions · doi:10.1042/bst20191283 · Cited by 22

Brain-derived neurotrophic factor modulates GAP-43 but not t?1 expression in injured retinal ganglion cells of adult rats

Fournier, A. E., Beer, J., Arregui, C. O., Essagian, C., Aguayo, A. J., & McKerracher, L. J. (1997) · Journal of Neuroscience Research · doi:10.1002/(sici)1097-4547(19970315)47:6 · Cited by 63

N-Methyl-d-aspartate Receptor Antagonists Have Variable Affect in 3-Nitropropionic Acid Toxicity

Nasr, P., Carbery, T., & Geddes, J. W. (2008) · Neurochemical Research · doi:10.1007/s11064-008-9809-3 · Cited by 17

Paeoniflorin isolated from Paeonia lactiflora attenuates osteoblast cytotoxicity induced by antimycin A

Choi, E. M., & Lee, Y. (2013) · Food & Function · doi:10.1039/c3fo60147a · Cited by 17

“CHEMICAL PRECONDITIONING” BY 3-NITROPROPIONATE REDUCES ISCHEMIA-REPERFUSION INJURY IN CARDIAC-ARRESTED RAT LUNGS1

Hirata, T., Fukuse, T., Ishikawa, S., Hanaoka, S., Chen, Q., Shoji, T., & Wada, H. (2001) · Transplantation · doi:10.1097/00007890-200102150-00003 · Cited by 17

HSF1 and Its Role in Huntington’s Disease Pathology

Kim, H., & Gómez‐Pastor, R. (2022) · Advances in experimental medicine and biology · doi:10.1007/5584_2022_742 · Cited by 21

Huntington's disease

Bonelli, R. M., & Beal, M. F. (2012) · Handbook of clinical neurology · doi:10.1016/b978-0-444-52002-9.00030-9 · Cited by 16

Animal welfare and the refinement of neuroscience research methods – a case study of Huntington's disease models

Olsson, I. A. S., Hansen, A. K., & Sandøe, P. (2008) · Laboratory Animals · doi:10.1258/la.2008.007147 · Cited by 16

The mitochondrial inhibitor malonate enhances NMDA toxicity in the neonatal rat striatum

Maragos, W. F., & Silverstein, F. S. (1995) · Developmental Brain Research · doi:10.1016/0165-3806(95)00085-r · Cited by 16

Excitotoxicity in the Brain

Fonnum, F. (1998) · Archives of toxicology. Supplement · doi:10.1007/978-3-642-46856-8_34 · Cited by 16

Honokiol protects osteoblastic MC3T3-E1 cells against antimycin A-induced cytotoxicity

Choi, E. M. (2011) · Inflammation Research · doi:10.1007/s00011-011-0360-3 · Cited by 15

Bioenergetic homeostasis decides neuroprotection or neurotoxicity induced by volatile anesthetics: A uniform mechanism of dual effects

Zhang, J., Zhou, W. M., & Qiao, H. (2011) · Medical Hypotheses · doi:10.1016/j.mehy.2011.04.018 · Cited by 15

Old mice present increased levels of succinate dehydrogenase activity and lower vulnerability to dyskinetic effects of 3-nitropropionic acid

Rosenstock, T. R., Abílio, V. C., Frussa‐Filho, R., Kiyomoto, B. H., & Smaili, S. S. (2008) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2008.08.011 · Cited by 15

Different patterns of axonal damage after intracerebral injection of malonate or AMPA

Cuthill, D., Fowler, J. H., McCulloch, J., & Dewar, D. (2006) · Experimental Neurology · doi:10.1016/j.expneurol.2006.03.021 · Cited by 15

Induction of apoptosis signal-regulating kinase 1 and oxidative stress mediate age-dependent vulnerability to 3-nitropropionic acid in the mouse striatum

Minn, Y., Cho, K., Kim, H., Kim, H., Suk, S., Lee, B. I., & Kim, G. W. (2007) · Neuroscience Letters · doi:10.1016/j.neulet.2007.10.042 · Cited by 14

Delayed Onset and Reduced Cognitive Deficits through Pre-Conditioning with 3-Nitropropionic Acid is Dependent on Sex and CAG Repeat Length in the R6/2 Mouse Model of Huntington’s Disease

Skillings, E. A., & Morton, A. J. (2016) · Journal of Huntington s Disease · doi:10.3233/jhd-160189 · Cited by 14

Cell-based technologies for Huntington's disease

Haddad, M. S., Wenceslau, C. V., Pompéia, C., & Kerkis, I. (2016) · Dementia & Neuropsychologia · doi:10.1590/s1980-5764-2016dn1004006 · Cited by 14

Acetyl-L-Carnitine Modulates TP53 and IL10 Gene Expression Induced by 3-NPA Evoked Toxicity in PC12 Cells

Virmani, A., Koverech, A., Ali, S. F., & BINIENDA, Z. K. (2011) · Current Neuropharmacology · doi:10.2174/157015911795017182 · Cited by 14

Striatal dopamine depletion and behavioural sensitization induced by methamphetamine and 3-nitropropionic acid

Eradiri, O. L., & Starr, M. S. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00776-1 · Cited by 14

An Integrated Strategy for Evaluation of Metabolic and Oxidative Defects in Neurodegenerative Illness Using Magnetic Resonance Techniques

Jenkins, B. G., Chen, Y. I., Küestermann, E. H. G. K., Makris, N., Nguyen, T., Kraft, E., Brownell, A., Rosas, H. D., Kennedy, D. N., Rosen, B. R., et al. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb07828.x · Cited by 14

Mitochondrial Biology and the Identification of Biomarkers of Huntington’s Disease

Neueder, A., & Orth, M. (2020) · Neurodegenerative Disease Management · doi:10.2217/nmt-2019-0033 · Cited by 13

The three sisters of fate: Genetics, pathophysiology and outcomes of animal models of neurodegenerative diseases

Klonarakis, M., Vos, M. D., Woo, E. K., Ralph, L. T., Thacker, J. S., & Gil‐Mohapel, J. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104541 · Cited by 14

Restoration of the striatal circuitry: from developmental aspects toward clinical applications

Pauly, M.-C., Piroth, T., Döbrössy, M. D., & Nikkhah, G. (2012) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2012.00016 · Cited by 13

Neuronal adenosine A2A receptor overexpression is neuroprotective towards 3-nitropropionic acid-induced striatal toxicity: a rat model of Huntington’s disease

Domenici, M. R., Chiodi, V., Averna, M., Armida, M., Pèzzola, A., Pepponi, R., Ferrante, A., Bäder, M., Fuxé, K., & Popoli, P. (2018) · Purinergic Signalling · doi:10.1007/s11302-018-9609-4 · Cited by 13

Endogenous Kynurenic Acid and Neurotoxicity

Urbańska, E. M., Chmiel-Perzyńska, I., Perzyński, A., Derkacz, M., & Owe‐Larsson, B. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_92 · Cited by 13

3-Nitropropionic Acid Neurotoxicity in Hippocampal Slice Cultures: Developmental and Regional Vulnerability and Dependency on Glucose

Noer, H., Kristensen, B. W., Noraberg, J., Zimmer, J., & Gramsbergen, J. B. (2002) · Experimental Neurology · doi:10.1006/exnr.2002.7934 · Cited by 13

Age-Dependent Biphasic Changes in Ischemic Sensitivity in the Striatum of Huntington's Disease R6/2 Transgenic Mice

Klapstein, G. J., & Levine, M. S. (2004) · Journal of Neurophysiology · doi:10.1152/jn.00483.2004 · Cited by 11

Protective effect of diazoxide against antimycin A-induced mitochondrial dysfunction in osteoblastic MC3T3-E1 cells

Choi, E. M. (2011) · Toxicology in Vitro · doi:10.1016/j.tiv.2011.06.004 · Cited by 12

Mechanisms of Neuronal Degeneration in Huntington’s Disease

Ferrante, R. J., Beal, M. F., & Kowall, N. W. (1994) · Advances in behavioral biology · doi:10.1007/978-1-4613-0485-2_15 · Cited by 12

Neuroprotective possibilities for Huntington’s disease

Emerich, D. F. (2001) · Expert Opinion on Biological Therapy · doi:10.1517/14712598.1.3.467 · Cited by 12

Age-related deficits in the ability to encode contextual change: A place cell analysis

Oler, J. A., & Markus, E. J. (2000) · Hippocampus · doi:10.1002/1098-1063(2000)10:3 · Cited by 58

Cytotoxicity models of Huntington’s disease and relevance of hormetic mechanisms: A critical assessment of experimental approaches and strategies

Calabrese, E. J., Bhatia, T. N., Calabrese, V., Dhawan, G., Giordano, J., Hanekamp, Y. N., Kapoor, R., Kozumbo, W. J., & Leak, R. K. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104371 · Cited by 12

Brief mitochondrial inhibition causes lasting changes in motor behavior and corticostriatal synaptic physiology in the Fischer 344 rat

Akopian, G. K., Crawford, C. A., Petzinger, G. M., Jakowec, M. W., & Walsh, J. P. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.04.060 · Cited by 10

Toxic animal models

Przedborski, S., & Tieu, K. (2005) · Cambridge University Press eBooks · doi:10.1017/cbo9780511544873.017 · Cited by 10

Enkephalinergic striatal projection neurons become less affected by quinolinic acid than substance P-containing striatal projection neurons as rats age

Sun, Z., Chen, Q., & Reiner, A. J. (2003) · Experimental Neurology · doi:10.1016/j.expneurol.2003.08.016 · Cited by 10

Protective effect of α-lipoic acid against antimycin A cytotoxicity in MC3T3-E1 osteoblastic cells

Lin, Z., Zhang, G., Liu, L., Chen, C., Cao, X., & Cai, J. (2016) · Cell Stress and Chaperones · doi:10.1007/s12192-016-0735-z · Cited by 9

Mice deficient in L-12/15 lipoxygenase show increased vulnerability to 3-nitropropionic acid neurotoxicity

He, Y., Akumuo, R. C., Yang, Y., & Hewett, S. J. (2017) · Neuroscience Letters · doi:10.1016/j.neulet.2017.02.031 · Cited by 9

Physiopathologie de la maladie de Huntington : état des connaissances

Roze, E. F., Bétuing, S., Deyts, C., Vidailhet, M., & Caboche, J. (2008) · Revue Neurologique · doi:10.1016/j.neurol.2008.03.006 · Cited by 11

Endogenous Kynurenic Acid and Neurotoxicity

Urbańska, E. M., Chmiel-Perzyńska, I., Perzyński, A., Derkacz, M., & Owe‐Larsson, B. (2021) · Springer eBooks · doi:10.1007/978-3-030-71519-9_92-1 · Cited by 9

Transgenic Model for the Study of Oxidative Damage in Huntington’s Disease

Segovia, J. (2002) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(02)53061-5 · Cited by 9

In vitro protection of 3-nitropropionic acid-induced toxicity of astrocytes by basic fibroblast growth factor and thrombin

Deshpande, S. B., & Nishino, H. (1998) · Brain Research · doi:10.1016/s0006-8993(97)01163-3 · Cited by 9

Chronic intrastriatal administration of quinolinic acid produces transient nocturnal hypermotility in the rat

Bazzett, T. J., Falik, R. C., Becker, J. B., & Albin, R. L. (1996) · Brain Research Bulletin · doi:10.1016/0361-9230(95)02043-8 · Cited by 9

Whole body hyperthermia reduces oxidative stress in the striatum of rats in an animal model of mitochondrial toxicity with 3-nitropropionic acid

Medina-Navarro, R., & Guerrero-Linares, I. (2009) · International Journal of Hyperthermia · doi:10.1080/02656730902744387 · Cited by 8

Regional selectivity of amyloid mRNA expression and neurotrophins on repetitive inhibition of oxidative phosphorylation

Arnim, C. A. F. V., Hellweg, R., B�chner, M., Huber, R., & Riepe, M. W. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0277-5 · Cited by 8

Altered open field behavior in rats induced by acute administration of 3-nitropropionic acid: Possible glutamatergic and dopaminergic involvement

Lukács, A., Szabó, A., Papp, A., & Vezér, T. (2009) · Acta Biologica Hungarica · doi:10.1556/abiol.60.2009.4.3 · Cited by 7

In vitro evidence supporting the therapeutic role of nicotine against neurodegeneration.

Williams, E., & Linert, W. (2004) · PubMed · Cited by 7

3-Nitropropionic Acid Model of Metabolic Stress: Assessment by Magnetic Resonance Imaging

Roberts, T. J. (2004) · Humana Press eBooks · doi:10.1385/1-59259-836-6:203 · Cited by 7

Challenges for basic research in glutaryl‐CoA dehydrogenase deficiency

Kölker, S., Strauss, K. A., Goodman, S. I., Hoffmann, G. F., Okun, J. G., & Koeller, D. M. (2004) · Journal of Inherited Metabolic Disease · doi:10.1023/b:boli.0000045768.38073.22 · Cited by 7

Consequences of Mitochondrial Dysfunction in Huntington's Disease and Protection via Phosphorylation Pathways

Cunha‐Oliveira, T., Lusa, I., & Cristina, A. (2012) · InTech eBooks · doi:10.5772/32728 · Cited by 6

Variable Susceptibility to Neurotoxicity of Systemic 3-Nitropropionic Acid

Alexi, T., Faull, R. L. M., & Hughes, P. E. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_9 · Cited by 7

Bioenergetics and excitotoxicity

Greene, J. G., & Greenamyre, J. T. (1996) · Elsevier eBooks · doi:10.1016/b978-012525445-8/50010-2 · Cited by 7

Survey of Selective Neurotoxins

Kostrzewa, R. M. (2014) · Springer eBooks · doi:10.1007/978-1-4614-5836-4_53 · Cited by 6

Effects of L‐Carnitine Pretreatment in Methamphetamine and 3‐Nitropropionic Acid‐Induced Neurotoxicity

BINIENDA, Z. K., PRZYBYLA, B. D., Robinson, B. L., Salem, N., Virmani, A., Amato, A., & Ali, S. F. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1369.006 · Cited by 6

Characterization of age-dependent changes in the striatum: Response to the mitochondrial toxin 3-nitropropionic acid

Shinomol, G. K., Ranganayaki, S., Joshi, A. K. R., Gayathri, N., Gowda, H., ., M., & Bharath, M. M. S. (2016) · Mechanisms of Ageing and Development · doi:10.1016/j.mad.2016.04.008 · Cited by 6

Chapter Two Evaluation of Some Cell Death Features by Real Time Real Space Microscopy

Smaili, S. S., Rosenstock, T. R., & Hsu, Y. (2008) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(08)01402-x · Cited by 6

The Use of the Mitochondrial Toxin 3-NP to Uncover Cellular Dysfunction in Huntington’s Disease

Hernández, E., la Rosa-Lpez, G. D., & Mendoza, E. (2012) · InTech eBooks · doi:10.5772/31284 · Cited by 6

3−Nitropropionic Acid Exacerbates [3H]GABA Release Evoked by Glucose Deprivation in Rat Striatal Slices

Boireau, A., Meunier, M., & Doble, A. (1996) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1996.tb05883.x · Cited by 6

Natural Products against Huntington's Disease ( HD ): Implications of Neurotoxic Animal Models and Transgenics in Preclinical Studies

Dey, A. (2017) · Wiley eBooks · doi:10.1002/9783527803781.ch8 · Cited by 6

Toxin Induced Mitochondrial Dysfunction and Neurodegeneration

Sabri, M. I. (1998) · Springer eBooks · doi:10.1007/978-3-662-12509-0_14 · Cited by 5

Experience of experimental modelling of Huntington’s disease

Stavrovskaya, A. V., Воронков, Д. Н., Yamshchikova, N. G., Olshanskiy, A. S., Худоерков, Р. М., & Illarioshkin, S. N. (2016) · Human Physiology · doi:10.1134/s0362119716080120 · Cited by 5

Malonic Acid and the Chronic Administration Model of Excitotoxicity

Bazzett, T. J., Albin, R. L., & Becker, J. B. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_15 · Cited by 5

The spatial and temporal relationship between oxidative stress and neuronal degeneration in 3-nitropropionic acid model

Delorme, T., Najafi, M., & Nasr, P. (2012) · World Journal of Neuroscience · doi:10.4236/wjns.2012.24036 · Cited by 5

5.5 Actions of Toxins on Cerebral Metabolism at the Cellular Level

Sonnewald, U., Syversen, T. L. M., Schousboe, A., Waagepetersen, H. S., & Aschner, M. (2007) · Springer eBooks · doi:10.1007/978-0-387-30411-3_21 · Cited by 5

No spatial memory deficit exists in Kunming mice that recently recovered from motor defects following 3-nitropropionic acid intoxication

Li, X.-M., Zhu, B., Ni, J., Cao, C.-Y., Zhang, J., Zhao, X., & Zhu, R.-S. (2009) · Neuroscience Bulletin · doi:10.1007/s12264-009-0105-2 · Cited by 5

Behavioral alterations in lewis rats following two-day continuous 3-nitropropionic acid administration

Newcomb, J. D., Brown, W. D., Rodríguez, A. I., Garbuzova-Davis, S., Saporta, S., Sanberg, P. R., & Willing, A. E. (2005) · Neurotoxicity Research · doi:10.1007/bf03033979 · Cited by 5

Cognitive and Motor Deficits Produced by Acute and Chronic Administration of 3-Nitropropionic Acid in Rats

Dunbar, G. L., Shear, D. A., Dong, J., & Haik-Creguer, K. L. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_5 · Cited by 5

Huntington Disease

Fahn, S., Jankovic, J. J., Hallett, M., & Jenner, P. G. (2007) · Elsevier eBooks · doi:10.1016/b978-0-443-07941-2.50018-8 · Cited by 5

Animal Models of Neurological Disorders

Deshmukh, R., & Bansal, P. (2017) · Springer eBooks · doi:10.1007/978-981-10-5981-0 · Cited by 5

Neurotoxins and Neurodegenerative Diseases

Ludolph, A. C. (1995) · Elsevier eBooks · doi:10.1016/b978-012168055-8/50051-0 · Cited by 5

Excitotoxic Lesions of the Rodent Striatum

Döbrössy, M. D., Büchele, F., & Nikkhah, G. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_2 · Cited by 4

Neuroprotective Effect of Boswellia serrata against 3-NP Induced Experimental Huntington’s Disease

Kumar, V., Sharma, C., Taleuzzaman, M., Nagarajan, K., Haque, A., Bhatia, M., Khan, S., Salkini, M. A., & Bhatt, P. (2024) · Current Bioactive Compounds · doi:10.2174/0115734072272233231119161319 · Cited by 4

Altered striatal vulnerability to 3-nitropropionic acid in rats due to sex hormone levels during late phase of brain development

Mogami, M., Hayashi, Y., Masuda, T., Kohri, K., Nishino, H., & Hida, H. (2008) · Neuroscience Letters · doi:10.1016/j.neulet.2008.03.055 · Cited by 4

Augmented pharmacologic stimulation of striatal acetylcholine release following developmental hypoxic-ischemic injury

Oo, T. F., Naini, A., & Burke, R. E. (1996) · Brain Research · doi:10.1016/0006-8993(95)01240-0 · Cited by 4

Acute effects of pulsed microwaves and 3‐nitropropionic acid on neuronal ultrastructure in the rat caudate‐putamen

Seaman, R. L., & Phelix, C. F. (2005) · Bioelectromagnetics · doi:10.1002/bem.20054 · Cited by 4

Use of genetically engineered mice as models for exploring the role of oxidative stress in neurodegenerative diseases

Andersen, J. K. (1998) · Frontiers in bioscience · doi:10.2741/a259 · Cited by 4

The Neurochemistry of 3-Nitropropionic Acid

Reynolds, N. C., & Lin, W. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-692-8_3 · Cited by 3

What Is the Role of Adenosine Tone and Adenosine Receptors in Huntington’s Disease?

Blum, D. L., Chern, E. C., Domenici, M. R., Buée, L., Lin, C. Y., Ferré, S., & Popoli, P. (2018) · Springer eBooks · doi:10.1007/978-3-319-90808-3_12 · Cited by 3

Bioenergetics in Oxidative Damage in Neurodegenerative Diseases

Beal, M. F. (1996) · Springer eBooks · doi:10.1007/978-1-4899-0209-2_22 · Cited by 3

Age dependence of striatal neuronal death caused by mitochondrial dysfunction

Bossi, S. R., Simpson, J. R., & Isacson, O. (1993) · Neuroreport · doi:10.1097/00001756-199301000-00019 · Cited by 80

3‐Nitropropionic acid: a mitochondrial toxin to uncover physiopathological mechanisms underlying striatal degeneration in Huntington's disease

Brouillet, E., Jacquard, C., Bizat, N., & Blum, D. L. (2005) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2005.03515.x · Cited by 371

Neurochemical and histologic characterization of striatal excitotoxic lesions produced by the mitochondrial toxin 3-nitropropionic acid

Beal, M. F., Brouillet, E., Jenkins, B. G., Ferrante, R. J., Kowall, N. W., Miller, J., Storey, E., Srivastava, R., Rosen, B. R., & Hyman, B. T. (1993) · Journal of Neuroscience · doi:10.1523/jneurosci.13-10-04181.1993 · Cited by 1,026

Mice Transgenic for the Huntington's Disease Mutation Are Resistant to Chronic 3‐Nitropropionic Acid‐Induced Striatal Toxicity

Hickey, M. A., & Morton, A. J. (2000) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2000.0752163.x · Cited by 53

3-Nitropropionic Acid and Other Metabolic Toxin Lesions of the Striatum

Borlongan, C. V., & Sanberg, P. R. (2011) · Neuromethods · doi:10.1007/978-1-61779-301-1_5